Sort
261,768 grants matching “gene therapy”
The Impact of DNA Damage Repair Abnormalities in Prostate Cancer
$1,929,187Philip W Kantoff · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Mechanisms of Sensory Hair Cell Survival and Death
$1,928,469Lisa L Cunningham · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC
Genome-wide study of sudden cardiac arrest in the community
$1,928,268David Siscovick · University Of Washington · R01 · FY2009 · HL
Long-acting PTH for hypoparathyroidism
$1,928,001Laura M Hales · Extend Biosciences, Inc. · R44 · FY2018 · DK
Validation of peripheral CGRP signaling as a target for the treatment of pain in chronic pancreatitis
$1,927,979Pankaj J Pasricha · Johns Hopkins University · R01 · FY2019 · DK
Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics
$1,927,847Leor S Weinberger · Autonomous Therapeutics, Inc. · R37 · FY2025 · AI
Emerging respiratory viruses - pathogenesis and countermeasures
$1,927,539Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,927,479Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
Development of Novel Therapeutic Strategies in Human Leukemias
$1,927,163Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2022 · CA
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
$1,927,027Victor John Thannickal · University Of Alabama At Birmingham · P01 · FY2015 · HL
GENERAL CLINICAL RESEARCH CENTER
$1,927,018Baylor College Of Medicine · M01 · FY2001 · RR
In Vivo Cellular and Molecular Imaging Center@Stanford
$1,926,940Sanjiv S Gambhir · Stanford University · P50 · FY2014 · CA
Growth Factor Imaging and Photoimmunotherapy
$1,926,705Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$1,925,677Peter Karl Sorger · Harvard Medical School · U54 · FY2022 · CA
Biology and Therapy of High Risk Neuroblastoma
$1,925,523Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2014 · CA
Gene Therapy for Alzheimer's Disease
$1,925,461Salk Institute For Biological Studies · P01 · FY2002 · AG
Cellular & Molecular Defects in Human B Cell Development
$1,925,282Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · AI
DNA virus as vectors for cardiovascular diseases
$1,925,010James M Wilson · University Of Pennsylvania · P01 · FY2006 · HL
Cellular & Molecular Defects in Human B Cell Development
$1,924,836Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2014 · AI
Cellular & Molecular Defects in Human B Cell Development
$1,924,821Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2015 · AI
Innate and Adaptive Immunity in Parkinson Disease
$1,924,770David G Standaert · University Of Alabama At Birmingham · P50 · FY2020 · NS
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,924,674Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells
$1,923,939Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2017 · HG
Childhood Cancer Gene Program Project Grant
$1,923,795St. Jude Children'S Research Hospital · P01 · FY2005 · CA
Prophylactic Anthrax Toxin Vaccine
$1,923,739Vical, Inc. · R44 · FY2003 · AI